Bill

Bill > HR1518


US HR1518

US HR1518
New Era of Preventing End-Stage Kidney Disease Act


summary

Introduced
02/24/2025
In Committee
02/24/2025
Crossed Over
Passed
Dead

Introduced Session

119th Congress

Bill Summary

A BILL To amend the Public Health Service Act with respect to preventing end-stage kidney disease, and for other purposes.

AI Summary

This bill aims to improve rare kidney disease research, prevention, diagnosis, and treatment through several key provisions. It establishes Centers of Excellence on Rare Kidney Disease Research within the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which will conduct research on rare kidney diseases, increase public awareness, and develop clinical research resources. The bill authorizes $6 million annually from 2026-2030 for these centers. Additionally, it mandates a comprehensive study by the Secretary of Health and Human Services to examine testing, preventative care, and treatment strategies for rare kidney diseases, including reviewing the impact of routine urinalysis, genetic testing, and barriers to diagnosis. The bill also focuses on enhancing provider education by modifying primary care training and nephrology fellowship programs to improve knowledge and care for populations disproportionately affected by rare kidney diseases. Furthermore, it requires the Secretary to conduct experiments to evaluate methods for treating rare kidney diseases with the goal of delaying or eliminating the need for dialysis and transplant, and to develop strategies for increasing public awareness. The legislation emphasizes addressing disparities in kidney disease diagnosis and treatment, particularly among racial and ethnic minorities, and aims to support research and education to improve patient outcomes.

Committee Categories

Business and Industry

Sponsors (65)

Gus Bilirakis (R)*,  Don Bacon (R),  Troy Balderson (R),  Jack Bergman (R),  Sanford Bishop (D),  Julia Brownley (D),  Janelle Bynum (D),  Mike Carey (R),  Kathy Castor (D),  Judy Chu (D),  Yvette Clarke (D),  Lou Correa (D),  Dan Crenshaw (R),  Jason Crow (D),  Henry Cuellar (D),  Danny Davis (D),  Don Davis (D),  Neal Dunn (R),  Veronica Escobar (D),  Brian Fitzpatrick (R),  Chuck Fleischmann (R),  Mike Flood (R),  Andrew Garbarino (R),  Al Green (D),  Abraham Hamadeh (R),  Glenn Ivey (D),  Jonathan Jackson (D),  Hank Johnson (D),  Bill Keating (D),  Jen Kiggans (R),  Young Kim (R),  Mike Lawler (R),  Susie Lee (D),  Mike Levin (D),  Ted Lieu (D),  Zoe Lofgren (D),  Sarah McBride (D),  Jim McGovern (D),  Rob Menendez (D),  Carol Miller (R),  Gwen Moore (D),  Jerry Nadler (D),  Eleanor Holmes Norton (D),  Jay Obernolte (R),  Alexandria Ocasio-Cortez (D),  Scott Peters (D),  Chellie Pingree (D),  Mark Pocan (D),  Deborah Ross (D),  Pat Ryan (D),  Brad Schneider (D),  Terri Sewell (D),  Chris Smith (R),  Darren Soto (D),  Haley Stevens (D),  Tom Suozzi (D),  Bennie Thompson (D),  Mike Thompson (D),  Rashida Tlaib (D),  Paul Tonko (D),  Jeff Van Drew (R),  Gabe Vasquez (D),  Eugene Vindman (D),  James Walkinshaw (D),  Joe Wilson (R), 

Last Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (on 02/24/2025)

Bill Topics

Health
  • ‐ Health Manpower and Training
  • ‐ Research and Development
  • ‐ Treatment of Specific Diseases

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location Created
State Bill Page https://www.congress.gov/bill/119th-congress/house-bill/1518/all-info 02/25/2025
BillText https://www.congress.gov/119/bills/hr1518/BILLS-119hr1518ih.pdf 03/20/2025
Loading...